(Q40826267)

24 September 2017

1 reference

title

Aerosol antibiotic treatment in cystic fibrosis (English)

1 reference

24 September 2017

0 references

Littlewood JM

1

1 reference

24 September 2017

Smye SW

series ordinal

2

1 reference

24 September 2017

Cunliffe H

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

Archives of Disease in Childhood

24 September 2017

1 reference

24 September 2017

68

1 reference

24 September 2017

6

1 reference

24 September 2017

788-792

1 reference

Inhaled aerosols: lung deposition and clinical applications

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Factors influencing the size distribution of aerosols from jet nebulisers

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Therapeutic aerosols 2--Drugs available by the inhaled route

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Local treatment of respiratory infections with antibiotics

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Drug delivery from jet nebulisers

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Evaluation of jet nebulisers for use with gentamicin solution

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Inhaled micronised gentamicin powder: a new delivery system

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Inhaled antibiotics in cystic fibrosis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Nebulisers: uses and abuses

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Some factors influencing the efficiency of a jet nebuliser system.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

A mathematical model of some aspects of jet nebuliser performance.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Measurement and prediction of drug solvent losses by evaporation from a jet nebuliser.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

In vitro comparison of DeVilbiss jet and ultrasonic nebulizers

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Why nebulise for more than five minutes?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029378

Efficacy of inhaled tobramycin in cystic fibrosis

19 August 2018

1 reference

12 December 2020

On the problem of fungal superinfections of the respiratory organs and their treatment with inhalations and instillations of amphotericin B and pure Moronal

1 reference

12 December 2020

Aerosol Chemotherapy in Bronchopulmonary Candidiasis

1 reference

12 December 2020

Effects of various inhalation modes on the deposition of radioactive pressurized aerosols

1 reference

12 December 2020

The role of antibiotics given by inhalation in chronic chest disease

1 reference

12 December 2020

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

12 December 2020

Assessment of jet nebulisers for lung aerosol therapy

1 reference

12 December 2020

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

12 December 2020

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes

1 reference

12 December 2020

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa

1 reference

12 December 2020

Improving the efficiency of drug administration with jet nebulisers

1 reference

12 December 2020

Long-term tobramycin aerosol therapy in cystic fibrosis

1 reference

12 December 2020

Importance of evaporative water losses during standardized nebulized inhalation provocation tests

1 reference

12 December 2020

Dilution of nebulised aerosols by air entrainment in children

1 reference

12 December 2020

Bronchial response to nebulized antibiotics in children with cystic fibrosis

1 reference

12 December 2020

Disposable jet nebulizers. How reliable are they?

1 reference

12 December 2020

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.68.6.788

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

8333776

1 reference